High affinity fusion proteins ("trapbodies"), capable of binding and inhibiting the activity of soluble, interacting proteins ("SIPs") are described. The trapbodies are multimers, preferably dimers, of SIP-specific fusion polypeptides which comprise SIP binding domains derived from SIP targets and/or anti-SIP immunoglobulins, as well as multimerizing components.